These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23035716)

  • 1. Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.
    Yu Z; Brannigan JA; Moss DK; Brzozowski AM; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
    J Med Chem; 2012 Oct; 55(20):8879-90. PubMed ID: 23035716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel and ligand-efficient inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferase.
    Rackham MD; Brannigan JA; Moss DK; Yu Z; Wilkinson AJ; Holder AA; Tate EW; Leatherbarrow RJ
    J Med Chem; 2013 Jan; 56(1):371-5. PubMed ID: 23170970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and in vitro evaluation of novel enantiomerically-pure sulphonamide antimalarials.
    Anusha S; Sinha A; Babu Rajeev CP; Chu TT; Mathai J; Ximei H; Fuchs JE; Shivananju N; Bender A; Preiser PR; Rangappa KS; Basappa ; Chandramohanadas R
    Org Biomol Chem; 2015 Nov; 13(43):10681-90. PubMed ID: 26347024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).
    Rackham MD; Brannigan JA; Rangachari K; Meister S; Wilkinson AJ; Holder AA; Leatherbarrow RJ; Tate EW
    J Med Chem; 2014 Mar; 57(6):2773-88. PubMed ID: 24641010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Selective Inhibitors of
    Harupa A; De Las Heras L; Colmenarejo G; Lyons-Abbott S; Reers A; Caballero Hernandez I; Chung CW; Charter D; Myler PJ; Fernández-Menéndez RM; Calderón F; Palomo S; Rodríguez B; Berlanga M; Herreros-Avilés E; Staker BL; Fernández Álvaro E; Kaushansky A
    J Med Chem; 2020 Jan; 63(2):591-600. PubMed ID: 31850752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Plasmodium vivax N-myristoyltransferase inhibitors: screening, synthesis, and structural characterization of their binding mode.
    Goncalves V; Brannigan JA; Whalley D; Ansell KH; Saxty B; Holder AA; Wilkinson AJ; Tate EW; Leatherbarrow RJ
    J Med Chem; 2012 Apr; 55(7):3578-82. PubMed ID: 22439843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Myristoylation as a Drug Target in Malaria: Exploring the Role of N-Myristoyltransferase Substrates in the Inhibitor Mode of Action.
    Schlott AC; Holder AA; Tate EW
    ACS Infect Dis; 2018 Apr; 4(4):449-457. PubMed ID: 29363940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from Plasmodium falciparum: an insight into novel antimalarial drug design.
    Paul P; Chowdhury A; Das Talukdar A; Choudhury MD
    J Mol Model; 2015 Mar; 21(3):37. PubMed ID: 25663521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors.
    Schlott AC; Mayclin S; Reers AR; Coburn-Flynn O; Bell AS; Green J; Knuepfer E; Charter D; Bonnert R; Campo B; Burrows J; Lyons-Abbott S; Staker BL; Chung CW; Myler PJ; Fidock DA; Tate EW; Holder AA
    Cell Chem Biol; 2019 Jul; 26(7):991-1000.e7. PubMed ID: 31080074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of N-myristoyltransferase as an antimalarial drug target using an integrated chemical biology approach.
    Wright MH; Clough B; Rackham MD; Rangachari K; Brannigan JA; Grainger M; Moss DK; Bottrill AR; Heal WP; Broncel M; Serwa RA; Brady D; Mann DJ; Leatherbarrow RJ; Tewari R; Wilkinson AJ; Holder AA; Tate EW
    Nat Chem; 2014 Feb; 6(2):112-21. PubMed ID: 24451586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Subsite Selectivity within
    Rodríguez-Hernández D; Fenwick MK; Zigweid R; Sankaran B; Myler PJ; Sunnerhagen P; Kaushansky A; Staker BL; Grøtli M
    J Med Chem; 2024 May; 67(9):7312-7329. PubMed ID: 38680035
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and Antimalarial Activity of 1,4-Disubstituted Piperidine Derivatives.
    Seck R; Gassama A; Cojean S; Cavé C
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31940857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
    Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
    Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Azaaurones derived from the naturally occurring aurones as potential antimalarial drugs.
    Souard F; Okombi S; Beney C; Chevalley S; Valentin A; Boumendjel A
    Bioorg Med Chem; 2010 Aug; 18(15):5724-31. PubMed ID: 20630767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclic nucleoside analogues as inhibitors of Plasmodium falciparum dUTPase.
    Nguyen C; Ruda GF; Schipani A; Kasinathan G; Leal I; Musso-Buendia A; Kaiser M; Brun R; Ruiz-Pérez LM; Sahlberg BL; Johansson NG; Gonzalez-Pacanowska D; Gilbert IH
    J Med Chem; 2006 Jul; 49(14):4183-95. PubMed ID: 16821778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analogues.
    Vallone A; D'Alessandro S; Brogi S; Brindisi M; Chemi G; Alfano G; Lamponi S; Lee SG; Jez JM; Koolen KJM; Dechering KJ; Saponara S; Fusi F; Gorelli B; Taramelli D; Parapini S; Caldelari R; Campiani G; Gemma S; Butini S
    Eur J Med Chem; 2018 Apr; 150():698-718. PubMed ID: 29571157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Plasmodium falciparum Lysyl-tRNA Synthetase via a Piperidine-Ring Scaffold Inspired Cladosporin Analogues.
    Babbar P; Sato M; Manickam Y; Mishra S; Harlos K; Gupta S; Parvez S; Kikuchi H; Sharma A
    Chembiochem; 2021 Jul; 22(14):2468-2477. PubMed ID: 33969584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second generation tetrahydroquinoline-based protein farnesyltransferase inhibitors as antimalarials.
    Bendale P; Olepu S; Suryadevara PK; Bulbule V; Rivas K; Nallan L; Smart B; Yokoyama K; Ankala S; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Buckner FS; Chakrabarti D; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2007 Sep; 50(19):4585-605. PubMed ID: 17722901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
    Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
    J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.